Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Vermeulen, Joëlle" or (type exact bookEditor and editor="Vermeulen, Joëlle")

Add to list
Circulating microRNA biomarkers for metastatic disease in neuroblastoma patients

Fjoralba Zeka (UGent) , Anneleen Decock (UGent) , Alan Van Goethem (UGent) , Katrien Vanderheyden, Fleur Demuynck, Tim Lammens (UGent) , Hetty Helsmoortel (UGent) , Joëlle Vermeulen, Rosa Noguera, Ana P. Berbegall, et al.

(2018) JCI INSIGHT. 3(23).
Add to list
- Conference Paper
- C3
Identifying and validating DNA methylation biomarkers: the example of neuroblastoma

Anneleen Decock (UGent) , Maté Ongenaert (UGent) , Jasmien Hoebeeck (UGent) , Katleen De Preter (UGent) , Gert Van Peer (UGent) , Wim Van Criekinge (UGent) , Ruth Ladenstein, Johannes H Schulte, Rosa Noguera, Raymond L Stallings, et al.

(2013) Belgian Society of Human Genetics, 13th Annual meeting, Abstracts.
Add to list
- Conference Paper
- C3
Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers

Anneleen Decock (UGent) , Maté Ongenaert (UGent) , Jasmien Hoebeeck (UGent) , Katleen De Preter (UGent) , Gert Van Peer (UGent) , Wim Van Criekinge (UGent) , Ruth Ladenstein, Johannes H Schulte, Rosa Noguera, Raymond L Stallings, et al.

(2013) Chromatin and Epigenetics, EMBO Conference series, Abstracts.
Add to list
- Conference Paper
- C3
Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers

Anneleen Decock (UGent) , Maté Ongenaert (UGent) , Jasmien Hoebeeck (UGent) , Katleen De Preter (UGent) , Gert Van Peer (UGent) , Wim Van Criekinge (UGent) , Ruth Ladenstein, Johannes H. Schulte, Rosa Noguera, Raymond L. Stallings, et al.

(2013) IUAP - P7/03 Progress Meeting 2013, Abstracts.
Add to list
- Journal Article
- A1
- open access
Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers.

Anneleen Decock (UGent) , Maté Ongenaert (UGent) , Jasmien Hoebeeck (UGent) , Katleen De Preter (UGent) , Gert Van Peer (UGent) , Wim Van Criekinge (UGent) , Ruth Ladenstein, Johannes H Schulte, Rosa Noguera, Raymond L Stallings, et al.

(2012) GENOME BIOLOGY. 13(10).
Add to list
- Conference Paper
- C3
Promoter methylation analysis identifies prognostic methylation biomarkers in neuroblastoma

Anneleen Decock (UGent) , Maté Ongenaert (UGent) , Jasmien Hoebeeck (UGent) , Katleen De Preter (UGent) , Gert Van Peer (UGent) , Wim Van Criekinge (UGent) , Ruth Ladenstein, Johannes H Schulte, Rosa Noguera, Raymond L Stallings, et al.

(2012) ANR Toronto 2012, Abstracts.
Add to list
Exon-level expression analyses identify MYCN and NTRK1 as major determinants of alternative exon usage and robustly predict primary neuroblastoma outcome

A Schramm, B Schowe, K Fielitz, M Heilmann, M Martin, T Marschall, J Köster, Jo Vandesompele (UGent) , Joëlle Vermeulen (UGent) , Katleen De Preter (UGent) , et al.

(2012) BRITISH JOURNAL OF CANCER. 107(8). p.1409-1417
Add to list
- Journal Article
- A1
- open access
Measurable impact of RNA quality on gene expression results from quantitative PCR

Joëlle Vermeulen (UGent) , Katleen De Preter (UGent) , Steve Lefever (UGent) , Justine Nuytens (UGent) , Fanny De Vloed (UGent) , Stefaan Derveaux (UGent) , Jan Hellemans, Franki Speleman (UGent) and Jo Vandesompele (UGent)

(2011) NUCLEIC ACIDS RESEARCH. 39(9).
Add to list
- Journal Article
- A1
- open access
A 6-gene signature identifies four molecular subgroups of neuroblastoma

Frida Abel, Daniel Dalevi, Maria Nethander, Rebecka Jörnsten, Katleen De Preter (UGent) , Joëlle Vermeulen (UGent) , Raymond Stallings, Per Kogner, John Maris and Staffan Nilsson

(2011) CANCER CELL INTERNATIONAL. 11.
Add to list
- Journal Article
- A1
- open access
The microRNA body map : dissecting microRNA function through integrative genomics

Pieter Mestdagh (UGent) , Steve Lefever (UGent) , Filip Pattyn (UGent) , Dana Ridzon, Erik Fredlund, Annelies Fieuw (UGent) , Maté Ongenaert (UGent) , Joëlle Vermeulen (UGent) , Anne De Paepe (UGent) , Linda Wong, et al.

(2011) NUCLEIC ACIDS RESEARCH. 39(20).
Add to list
miRNA Expression profiling enables risk stratification in archived and fresh neuroblastoma tumor samples

Katleen De Preter (UGent) , Pieter Mestdagh (UGent) , Joëlle Vermeulen (UGent) , Fjoralba Zeka (UGent) , Alene Naranjo, Isabella Bray, Victoria Castel, Caifu Chen, Elzbieta Drozynska, Angelika Eggert, et al.

(2011) CLINICAL CANCER RESEARCH. 17(24). p.7684-7692
Add to list
Predicting outcomes for children with neuroblastoma

Joëlle Vermeulen (UGent) , Katleen De Preter (UGent) , Pieter Mestdagh (UGent) , Genevieve Laureys (UGent) , Franki Speleman (UGent) and Jo Vandesompele (UGent)

(2010) DISCOVERY MEDICINE. 10(50). p.29-36
Add to list
- Conference Paper
- C3
The miRNA body map: dissecting miRNA function through integrative genomics

Pieter Mestdagh (UGent) , Steve Lefever (UGent) , Filip Pattyn (UGent) , Dana Ridzon, Erik Fredlund, Annelies Fieuw (UGent) , Joëlle Vermeulen (UGent) , Anne De Paepe (UGent) , Linda Wong, Franki Speleman (UGent) , et al.

(2010) MicroRNAs Europe, Meeting abstracts.
Add to list
Accurate prediction of neuroblastoma outcome based on miRNA expression profiles

Johannes H Schulte, Benjamin Schowe, Pieter Mestdagh (UGent) , Lars Kaderali, Prabhav Kalaghatgi, Stefanie Schlierf, Joëlle Vermeulen (UGent) , Bent Brockmeyer, Kristian Pajtler, Theresa Thor, et al.

(2010) INTERNATIONAL JOURNAL OF CANCER. 127(10). p.2374-2385
Add to list
- Conference Paper
- C3
Accurate prediction of neuroblastoma outcome based on miRNA expression profiles

Johannes Schulte, Benjamin Schowe, Pieter Mestdagh (UGent) , Lars Kaderali, Prabhav Kalaghatgi, Stefanie Schlierf, Joëlle Vermeulen (UGent) , Bent Brockmeyer, Kristian Pajtler, Theresa Thor, et al.

(2010) PEDIATRIC BLOOD & CANCER. 55(5). p.812-812

Academic Bibliography

Circulating microRNA biomarkers for metastatic disease in neuroblastoma patients

Identifying and validating DNA methylation biomarkers: the example of neuroblastoma

Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers

Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers

Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers.

Promoter methylation analysis identifies prognostic methylation biomarkers in neuroblastoma

Exon-level expression analyses identify MYCN and NTRK1 as major determinants of alternative exon usage and robustly predict primary neuroblastoma outcome

Measurable impact of RNA quality on gene expression results from quantitative PCR

A 6-gene signature identifies four molecular subgroups of neuroblastoma

The microRNA body map : dissecting microRNA function through integrative genomics

miRNA Expression profiling enables risk stratification in archived and fresh neuroblastoma tumor samples

Predicting outcomes for children with neuroblastoma

The miRNA body map: dissecting miRNA function through integrative genomics

Accurate prediction of neuroblastoma outcome based on miRNA expression profiles

Accurate prediction of neuroblastoma outcome based on miRNA expression profiles

Contents

Support

Contact